We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Computers Used to Detect Alzheimer's in MRI Brain Scans

By MedImaging staff writers
Posted on 14 Apr 2008
Computers are now being trained to detect early signs of Alzheimer's disease (AD) in magnetic resonance imaging (MRI) brain scans, according to recent research.

Researchers from the Mayo Clinic in Scottsdale (Arizona, USA) and other participating centers were able to diagnose AD successfully, using software that detected the difference between MRI brain scans of those with Alzheimer's and those without the disease with accuracy as high as 96%. More...
The study also revealed that the computer-based diagnostic method could effectively differentiate patients with AD from those with frontotemporal lobar degeneration, a form of dementia involving degeneration of gray matter. The findings were published in the March 2008 issue of the journal Brain.

Data from different medical centers, using scans from different equipment, were combined, and the findings proved compatible. "Currently, MRI scans are not used clinically to diagnose Alzheimer's disease, but rather to rule out diseases such as stroke or tumors. This research finding could enable physicians to use MRI scans for diagnosing the condition earlier and more accurately,” stated Cynthia M. Stonnington, M.D., a specialist in psychiatry at Mayo Clinic and one of the authors of the study.

The investigators used the software to analyze brain scans of individuals for whom Alzheimer's had been pathologically confirmed. The software was able to compare the information with images of healthy brains, and use the data to diagnose new sets of images.

AD is the most common cause of dementia, which is the loss of intellectual and social abilities severe enough to impede with daily functioning tasks. Dementia occurs in people with Alzheimer's disease because healthy brain tissue degenerates, causing a steady decline in memory and mental abilities. Although there is no cure for AD, researchers have made progress. Treatments are available that improve the quality of life for some people with Alzheimer's. Furthermore, more drugs are being evaluated, and scientists have discovered several genes associated with AD, which may lead to new treatments to block progression of this complex disease.

Researchers explained in their study that a major advantage of using computers to assist in diagnosing AD is that they may prove less expensive, faster, and more accurate than the current method. "The next step is to see whether we can use the technique to diagnose disease pre-symptomatically,” stated Dr. Stonnington.


Related Links:
Mayo Clinic

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.